NPS Pharmaceuticals, Inc. President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young LLP Entrepreneur of the Year® 2013

Published: May 16, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief executive officer Francois Nader, M.D. has been named a finalist for the Ernst & Young Entrepreneur Of The Year® 2013 Award in the New Jersey region. The awards program recognizes high-growth entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.

Help employers find you! Check out all the jobs and post your resume.

Back to news